Citi-coline for babies who had low oxygen at birth
Part of Genetic & congenital clinical trials.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a newborn baby who experienced low oxygen (hypoxia) around birth
- Do not have hypoxic ischemic encephalopathy (a specific severe brain injury from low oxygen)
- Be eligible for study screening based on the medical cause of the low-oxygen event
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
This trial tests if citicoline, a brain-protecting supplement, can help newborns with moderate to severe brain injury from lack of oxygen. It is for babies who have not gotten cooling treatment.
This trial tests whether a medicine called citicoline can help newborns who had a brief lack of oxygen around birth, which can affect their brain. It aims to see if the medicine improves their recovery and brain blood flow.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
This trial is testing a treatment for newborns who had low oxygen around birth, leading to brain injury. It may help babies who did not get certain medicines before birth.
This trial tests whether adding sildenafil to standard cooling treatment helps newborns who had a lack of oxygen to the brain. It aims to see if this combination can reduce brain damage and improve outcomes.
Hear when a new Neonatal Hypoxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.